Cannabis and psychosis - Authors' reply
- PMID: 26360275
- DOI: 10.1016/S2215-0366(15)00177-7
Cannabis and psychosis - Authors' reply
Comment on
-
Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study.Lancet Psychiatry. 2015 Mar;2(3):233-8. doi: 10.1016/S2215-0366(14)00117-5. Epub 2015 Feb 25. Lancet Psychiatry. 2015. PMID: 26359901
-
Cannabis and psychosis.Lancet Psychiatry. 2015 May;2(5):380. doi: 10.1016/S2215-0366(15)00108-X. Epub 2015 Apr 28. Lancet Psychiatry. 2015. PMID: 26360272 No abstract available.
-
Cannabis and psychosis.Lancet Psychiatry. 2015 May;2(5):380-381. doi: 10.1016/S2215-0366(15)00113-3. Epub 2015 Apr 28. Lancet Psychiatry. 2015. PMID: 26360273 No abstract available.
-
Cannabis and psychosis.Lancet Psychiatry. 2015 May;2(5):381-382. doi: 10.1016/S2215-0366(15)00167-4. Epub 2015 Apr 28. Lancet Psychiatry. 2015. PMID: 26360274 No abstract available.
Similar articles
-
High-potency cannabis and incident psychosis: correcting the causal assumption - Authors' reply.Lancet Psychiatry. 2019 Jun;6(6):466-467. doi: 10.1016/S2215-0366(19)30176-2. Lancet Psychiatry. 2019. PMID: 31122474 No abstract available.
-
Cannabis use and non-cancer chronic pain - Authors' reply.Lancet Public Health. 2018 Oct;3(10):e469. doi: 10.1016/S2468-2667(18)30182-8. Lancet Public Health. 2018. PMID: 30314592 Free PMC article. No abstract available.
-
Cannabidiol for cannabis use disorder: too high hopes? - Authors' reply.Lancet Psychiatry. 2020 Oct;7(10):840. doi: 10.1016/S2215-0366(20)30376-X. Lancet Psychiatry. 2020. PMID: 32949514 No abstract available.
-
Cannabis psychosis: examining the evidence for a distinctive psychopathology in a systematic and narrative review.Am J Addict. 2012 Nov;21 Suppl 1:S88-98. doi: 10.1111/j.1521-0391.2012.00295.x. Am J Addict. 2012. PMID: 23786516 Review.
-
Cannabis and psychosis.Curr Psychiatry Rep. 2002 Jun;4(3):191-6. doi: 10.1007/s11920-002-0026-5. Curr Psychiatry Rep. 2002. PMID: 12003681 Review.
Cited by
-
First-Episode Psychosis Patients Who Deteriorated in the Premorbid Period Do Not Have Higher Polygenic Risk Scores Than Others: A Cluster Analysis of EU-GEI Data.Schizophr Bull. 2023 Jan 3;49(1):218-227. doi: 10.1093/schbul/sbac100. Schizophr Bull. 2023. PMID: 35947471 Free PMC article.
-
Premorbid Adjustment and IQ in Patients With First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship With Cannabis Use.Schizophr Bull. 2020 Apr 10;46(3):517-529. doi: 10.1093/schbul/sbz077. Schizophr Bull. 2020. PMID: 31361020 Free PMC article.
-
Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis.World Psychiatry. 2016 Oct;15(3):195-204. doi: 10.1002/wps.20341. World Psychiatry. 2016. PMID: 27717258 Free PMC article.
-
New Clinically Relevant Findings about Violence by People with Schizophrenia.Can J Psychiatry. 2017 Feb;62(2):86-93. doi: 10.1177/0706743716648300. Epub 2016 Jul 11. Can J Psychiatry. 2017. PMID: 27605579 Free PMC article. Review.
-
Bridging the gap between research into biological and psychosocial models of psychosis.Shanghai Arch Psychiatry. 2015 Jun 25;27(3):139-43. doi: 10.11919/j.issn.1002-0829.215067. Shanghai Arch Psychiatry. 2015. PMID: 26300595 Free PMC article.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources